Dimple Bhatia - Concepedia

Author

Dimple Bhatia

Piramal (India)ORCID

Also Known As

Dimple Bhatia, Dimple R Bhatia, Dimple R. Bhatia

Publications

441

Citations

H-Index

Concepts

All Affiliations

Piramal (India)

About

Dimple Bhatia is an author at Piramal (India) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	114
2	Natural Sciences	2	2	62
3	Biochemistry	2	2	62
4	Cell Biology	1	1	17
5	Chemical Biology	1	1	16

Dimple Bhatia

Publications

371

Citations

H-Index

Page 1

	Year	Citations
WebFlow - a visual programming paradigm for Web/Java based coarse grain distributed computing Dimple Bhatia, Vanco Burzevski, Maja Camuseva, Concurrency Practice and Experience	1997	100
P276-00, a novel cyclin-dependent inhibitor induces G1-G2 arrest, shows antitumor activity on cisplatin-resistant cells and significant <i>in vivo</i> efficacy in tumor models Kalpana Joshi, Maggie J. Rathos, P. Mahajan, Molecular Cancer Therapeutics	2007	74
DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma Allison A. Fitzgerald, Shangzi Wang, Veena R. Agarwal, Journal for ImmunoTherapy of Cancer	2021	72
Anticancer activity of Ophiobolin A, isolated from the endophytic fungus <i>Bipolaris setariae</i> Dimple Bhatia, Payal Dhar, Varun Mutalik, Natural Product Research Chemoprevention StrategyPathologyMedicinal FungiTumor BiologyMedicinal Chemistry	2015	46
A novel mTOR inhibitor is efficacious in a murine model of colitis Mandar Bhonde, Ravindra D. Gupte, Shruta D. Dadarkar, American Journal of Physiology-Gastrointestinal and Liver Physiology InflammationCytokineAnti-inflammatoryMucosal ImmunologyMedicine	2008	35
P7170: A Novel Molecule with Unique Profile of mTORC1/C2 and Activin Receptor-like Kinase 1 Inhibition Leading to Antitumor and Antiangiogenic Activity Archana Jalota‐Badhwar, Dimple Bhatia, Srinivas Reddy Boreddy, Molecular Cancer Therapeutics Antiangiogenic ActivityCancer ResearchNovel MoleculeMedicineReceptor Tyrosine Kinase	2015	17
Design and synthesis of novel furoquinoline based inhibitors of multiple targets in the PI3K/Akt-mTOR pathway Manoj V. Lohar, Ramswaroop Mundada, Mandar Bhonde, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryNovel FuroquinolineBiochemistryMedicineMultiple Targets	2008	16
P7170, a novel inhibitor of mTORC1/mTORC2 and Activin receptor-like Kinase 1 (ALK1) inhibits the growth of non small cell lung cancer Venkatasubbaiah A. Venkatesha, Asavari Joshi, V. Magesh, Molecular Cancer	2014	11

Page 1